BACK
|Weight Loss,Enrolling
Pfizer Obesity
This study is looking at a once daily pill (PF-07976016) in combination with Liraglutide which is an approved GLP-1R agonist in patients with obesity.
This study is looking at a once daily pill (PF-07976016) in combination with Liraglutide which is an approved GLP-1R agonist in patients with obesity.